Medical Oncology

Non-Hodgkin Lymphoma   

Questions discussed in this category



Are there other mutations/biomarkers in CLL which may specifically predict for response or resistance to pirtobrutinib?

In a patient who relapsed following 2nd line transplant, how do you select CAR-T vs bispecifics vs non-T-cell-mediated therapies as outlined in NCCN? ...

Do you speak to different expectations re: ability to achieve PR/CR and/or how this will impact ability to get to later therapies for a patient with p...

NCCN guideline V4.2021 DLBCL page BCEL-3 states stage I-II, bulky >= 7.5cm should be treated with 6 cycles of RCHOP, but most bone lymphoma studies...

Do you prefer a cHL chemotherapy backbone or PMBL chemotherapy backbone?

What if the patient has a history of confirmed COVID-19 but has since recovered?


Papers discussed in this category


Blood, 2021 Mar 08

International journal of radiation oncology, biology, physics, 2019-12-01

The Lancet. Oncology, 2019-01

Molecular therapy : the journal of the American Society of Gene Therapy, 2018-11-07

Cancer immunology research, 2019-07

Br J Haematol, 2020 Mar 5

Lancet, 2020 Sep 01

Blood Adv,

Int J Radiat Oncol Biol Phys, 2020 May 22

The New England journal of medicine, 2017-12-28

Radiother Oncol, 2021 Dec 7

Int J Radiat Oncol Biol Phys, 2021 Dec 1

Int J Radiat Oncol Biol Phys, 2022 Dec 20

Transplant Cell Ther, 2022 Dec 30

Blood advances, 2020 Jul 28

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022 Oct 26

Blood advances, 2020 Nov 24

Haematologica, 2023 Jun 15

J Clin Oncol, 2017 Jan 17

J Clin Oncol, 2023 May 16

N Engl J Med, 2021 Dec 11

The New England journal of medicine, 2022 Feb 24

N Engl J Med, 2023 Jul 6

Blood advances, 2023 Jun 27

Blood advances, 2022 Oct 25

The Lancet. Oncology, 2018-01

The New England journal of medicine, 2018-03-22

Blood advances, 2024 Mar 26

Haematologica, 2024 Jun 01